Drug Profile
AUD 79C
Latest Information Update: 02 Feb 2001
Price :
$50
*
At a glance
- Originator Taiho Pharmaceutical
- Class Antihistamines; Antiulcers; Cytoprotectives; Gastric antisecretories
- Mechanism of Action Histamine H2 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Gastric ulcer
Most Recent Events
- 02 Feb 2001 Profile reviewed but no significant changes made
- 10 Jul 1998 No-Development-Reported for Gastric ulcer in Japan (Unknown route)
- 05 May 1995 New profile